55 Chapel Street, Suite 202, Newton, Ma 02458

75 Gilcreast Road, Suite 305, Londonderry, NH 03053

Thank you for visiting. NESCA Notes has moved!

For articles after June 4, 2018 please visit nesca-newton.com/nesca-notes/.

Search This Blog

Thursday, October 11, 2012

Recruiting Research Subjects: Mass. General Hospital for Children at The Lurie Center

Guanfacine and Methylphenidate in the Treatment of Hyperactivity in Children with Pervasive Developmental Disorders

The Massachusetts General Hospital for Children at the Lurie Center in Lexington, MA is conducting a research study for children 5–14 years old who have Pervasive Developmental Disorders (Autism, Asperger’s Disorder, or PDD-NOS).

If your 5 - 14 year old has Autism, Asperger’s Disorder, or PDD-NOS, he or she may qualify for a research study involving study medication and clinic visits with a child psychiatrist and qualified research staff at no charge.

The purpose of this study is to find out if the medication, extended release guanfacine, is helpful for the treatment of hyperactivity and impulsiveness in children. 

Participation requirements and risks involved in this study will be disclosed prior to study enrollment. If you are interested in participating or would like more information, please contact the Lurie Center at 781-860-1711 or LurieCenterResearch@partners.org.

No comments:

Post a Comment